Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Atara Biotherapeutics, Inc. (ATRA) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$0.52M |
|
$-4.14M |
|
$0.12M |
|
$0.39M |
|
$3.88M |
|
$-3.37M |
|
$-0.78M |
|
$-4.14M |
|
$-4.14M |
|
$-4.14M |
|
$-4.14M |
|
$-4.14M |
|
$-4.14M |
|
$-3.37M |
|
$-3.34M |
|
14.08M |
|
14.08M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$12.17M |
|
$0.06M |
|
$7.82M |
|
$20.00M |
|
$5.64M |
|
-- |
|
$51.66M |
|
$57.31M |
|
$-37.31M |
|
$-37.31M |
|
$-37.31M |
|
8.51M |
|
| Cash Flow Statement Financials | |
$-3.07M |
|
-- |
|
$2.95M |
|
$8.48M |
|
$8.36M |
|
$-0.12M |
|
$0.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.16 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
75.97% |
|
-652.91% |
|
-652.91% |
|
-- |
|
-803.29% |
|
-803.29% |
|
$-3.07M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
11.11% |
|
11.11% |
|
-20.73% |
|
11.11% |
|
$-4.38 |
|
$-0.22 |
|
$-0.22 |
|